OIF Annual Scientific Meeting 2025 in Chicago “Translating discoveries into therapies” Written by Lidiia Zhytnik, OIFE Advisory Board Member The 25th annual OIF Investigator meeting took place 9-11 of April 2025. Traditionally held in Chicago, the OIF investigator meeting invites more than 100 top (almost exclusively) US and Canada scientists and clinicians working on improving…
In OIFE Magazine 2-2021 we published an interview with Brendan Lee, M.D. Ph.D., Baylor College of Medicine, Houston, Texas about research on the potential therapy Fresolimumab (TGFb). Who are you and what is your relationship to OI? I am a pediatrician and clinical geneticist who has engaged in basic, translational, and clinical research in skeletal…
Clinical trial: Investigating Denosumab in children with OI Interview with Dr. Jörg Oliver Semler, Paediatrician, OIFE Medical Advisory Board (MAB) How did the project of investigating denosumab in children start? Regarding the use of denosumab in OI there are a few projects which have to be separated. At the beginning there were a few case…
By Dr. Antonella Forlino, member of OIFE’s Medical Advisory Board Report from OIF Investigator meeting 2019 It was a great pleasure to be sponsored by OIFE to participate at the 19th Annual OI Foundation (OIF) Scientific Meeting held in Chicago on April 10-12 and co-chaired by Dr Marini and Dr Raggio. The American Scientific Community…
